Empirical Bayes estimation of random effects of a mixed-effects proportional odds Markov model for ordinal data

The objective of this work was to investigate the factors influencing the quality of empirical Bayes estimates (EBEs) of individual random effects of a mixed-effects Markov model for ordered categorical data. It was motivated by an attempt to develop a model-based dose adaptation tool for clinical use in colorectal cancer patients receiving capecitabine, which induces severe hand-and-foot syndrome (HFS) toxicity in more than a half of the patients. This simulation-based study employed a published mixed-effects model for HFS. The quality of EBEs was assessed in terms of accuracy and precision, as well as shrinkage. Three optimization algorithms were compared: simplex, quasi-Newton and adaptive random search. The investigated factors were amount of data per patient, distribution of categories within patients, magnitude of the inter-individual variability, and values of the effect model parameters. The main factors affecting the quality of EBEs were the values of parameters governing the dose-response relationship and the within-subject distribution of categories. For the chosen HFS toxicity model, the accuracy and precision of EBEs were rather low, and therefore the feasibility of their use for individual model-based dose adaptation seemed limited.

[1]  Peter Congdon Bayesian statistical modelling , 2002 .

[2]  W F Ebling,et al.  Is it possible to estimate the parameters of the sigmoid Emax model with truncated data typical of clinical studies? , 1996, Journal of pharmaceutical sciences.

[3]  David B. Dunson,et al.  Bayesian Data Analysis , 2010 .

[4]  Lynn McFadyen,et al.  A Two-Part Mixture Model for Longitudinal Adverse Event Severity Data , 2003, Journal of Pharmacokinetics and Pharmacodynamics.

[5]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..

[6]  Tao Ye,et al.  A recursive random search algorithm for network parameter optimization , 2004, PERV.

[7]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[8]  Gordon Graham,et al.  Determination of an Optimal Dosage Regimen Using a Bayesian Decision Analysis of Efficacy and Adverse Effect Data , 2002, Journal of Pharmacokinetics and Pharmacodynamics.

[9]  E. Niclas Jonsson,et al.  PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM , 2005, Comput. Methods Programs Biomed..

[10]  D. Mould,et al.  Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumors , 2002, Clinical pharmacology and therapeutics.

[11]  C. Twelves,et al.  A Dynamic Model of Hand‐and‐Foot Syndrome in Patients Receiving Capecitabine , 2009, Clinical pharmacology and therapeutics.

[12]  W. Press Numerical recipes in Fortran 77 : the art of scientific computing : volume 1 of fortran numerical recipes , 1996 .

[13]  France Mentré,et al.  Implementation and Evaluation of the SAEM Algorithm for Longitudinal Ordered Categorical Data with an Illustration in Pharmacokinetics–Pharmacodynamics , 2010, The AAPS Journal.

[14]  Ss Beal,et al.  NONMEM User’s Guides. (1989–2009) , 2009 .

[15]  R. Savic,et al.  Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions , 2009, The AAPS Journal.

[16]  A. Dunne,et al.  Mixed Effects versus Fixed Effects Modelling of Binary Data with Inter-subject Variability , 2005, Journal of Pharmacokinetics and Pharmacodynamics.

[17]  Siv Jönsson,et al.  Estimating Bias in Population Parameters for Some Models for Repeated Measures Ordinal Data Using NONMEM and NLMIXED , 2004, Journal of Pharmacokinetics and Pharmacodynamics.

[18]  France Mentré,et al.  Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs , 2001, Comput. Methods Programs Biomed..

[19]  R. Kass Nonlinear Regression Analysis and its Applications , 1990 .

[20]  R. Gieschke,et al.  Modelling Response Time Profiles in the Absence of Drug Concentrations: Definition and Performance Evaluation of the K–PD Model , 2007, Journal of Pharmacokinetics and Pharmacodynamics.